Metropolitan Life Insurance Company (MetLife)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-10,087
| Closed | -$51.2K | – | 260 |
|
2024
Q1 | $51.2K | Sell |
10,087
-1,545
| -13% | -$7.85K | ﹤0.01% | 1395 |
|
2023
Q4 | $69.7K | Hold |
11,632
| – | – | ﹤0.01% | 1271 |
|
2023
Q3 | $82.4K | Buy |
11,632
+1,604
| +16% | +$11.4K | ﹤0.01% | 1121 |
|
2023
Q2 | $70.6K | Hold |
10,028
| – | – | ﹤0.01% | 1214 |
|
2023
Q1 | $83.6K | Sell |
10,028
-1,438
| -13% | -$12K | ﹤0.01% | 1098 |
|
2022
Q4 | $132K | Buy |
11,466
+364
| +3% | +$4.18K | 0.01% | 917 |
|
2022
Q3 | $140K | Hold |
11,102
| – | – | 0.01% | 829 |
|
2022
Q2 | $117K | Hold |
11,102
| – | – | 0.01% | 969 |
|
2022
Q1 | $181K | Sell |
11,102
-36,266
| -77% | -$590K | 0.01% | 867 |
|
2021
Q4 | $656K | Hold |
47,368
| – | – | 0.01% | 1244 |
|
2021
Q3 | $681K | Sell |
47,368
-4,706
| -9% | -$67.6K | 0.01% | 1237 |
|
2021
Q2 | $823K | Buy |
52,074
+4,089
| +9% | +$64.6K | 0.01% | 1158 |
|
2021
Q1 | $488K | Sell |
47,985
-3,484
| -7% | -$35.4K | 0.01% | 1425 |
|
2020
Q4 | $383K | Sell |
51,469
-2,325
| -4% | -$17.3K | 0.01% | 1538 |
|
2020
Q3 | $185K | Buy |
53,794
+3,105
| +6% | +$10.7K | ﹤0.01% | 1819 |
|
2020
Q2 | $242K | Sell |
50,689
-1
| -0% | -$5 | ﹤0.01% | 1680 |
|
2020
Q1 | $101K | Buy |
50,690
+313
| +0.6% | +$626 | ﹤0.01% | 2022 |
|
2019
Q4 | $174K | Buy |
50,377
+13,406
| +36% | +$46.3K | ﹤0.01% | 2020 |
|
2019
Q3 | $106K | Hold |
36,971
| – | – | ﹤0.01% | 2273 |
|
2019
Q2 | $140K | Hold |
36,971
| – | – | ﹤0.01% | 2129 |
|
2019
Q1 | $301K | Hold |
36,971
| – | – | 0.01% | 1636 |
|
2018
Q4 | $298K | Buy |
36,971
+1,067
| +3% | +$8.61K | 0.01% | 1551 |
|
2018
Q3 | $274K | Buy |
35,904
+4,590
| +15% | +$35K | ﹤0.01% | 1786 |
|
2018
Q2 | $179K | Hold |
31,314
| – | – | ﹤0.01% | 2013 |
|
2018
Q1 | $149K | Buy |
31,314
+4,491
| +17% | +$21.4K | ﹤0.01% | 2078 |
|
2017
Q4 | $132K | Sell |
26,823
-33,253
| -55% | -$164K | ﹤0.01% | 2151 |
|
2017
Q3 | $315K | Sell |
60,076
-50
| -0.1% | -$262 | ﹤0.01% | 2001 |
|
2017
Q2 | $334K | Hold |
60,126
| – | – | ﹤0.01% | 1986 |
|
2017
Q1 | $505K | Buy |
60,126
+3,339
| +6% | +$28K | ﹤0.01% | 1648 |
|
2016
Q4 | $359K | Sell |
56,787
-4,399
| -7% | -$27.8K | ﹤0.01% | 1956 |
|
2016
Q3 | $270K | Sell |
61,186
-2,330
| -4% | -$10.3K | ﹤0.01% | 2138 |
|
2016
Q2 | $180K | Buy |
+63,516
| New | +$180K | ﹤0.01% | 2388 |
|
2016
Q1 | – | Sell |
-52,196
| Closed | -$539K | – | 2508 |
|
2015
Q4 | $539K | Hold |
52,196
| – | – | ﹤0.01% | 1578 |
|
2015
Q3 | $595K | Hold |
52,196
| – | – | ﹤0.01% | 1524 |
|
2015
Q2 | $779K | Buy |
+52,196
| New | +$779K | 0.01% | 1450 |
|
2015
Q1 | – | Sell |
-54,718
| Closed | -$665K | – | 2234 |
|
2014
Q4 | $665K | Hold |
54,718
| – | – | ﹤0.01% | 1568 |
|
2014
Q3 | $535K | Hold |
54,718
| – | – | ﹤0.01% | 1674 |
|
2014
Q2 | $698K | Buy |
+54,718
| New | +$698K | ﹤0.01% | 1591 |
|